Want to see HK:2185 full AI Analyst Report?
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) Income Statement
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Income Statement
Last quarter (Q2 2026), Shanghai Bio-Heart Biological Technology Co., Ltd. Class H's total revenue was $14.18M. In Q2, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H's net income was $-32.21M. See Shanghai Bio-Heart Biological Technology Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 43.77M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -157.81K | $ 0.00 | $ -23.60M | $ -24.25M | $ -13.27M | |
| $ 69.68M | $ 61.04M | $ 146.27M | $ 269.02M | $ 409.65M | |
| Depreciation and Amortization | $ 17.71M | $ 8.17M | $ 21.36M | $ 20.86M | $ 13.23M |
| $ -52.13M | $ -52.87M | $ -143.27M | $ -229.43M | $ -396.42M | |
| $ -69.84M | $ -61.04M | $ -164.62M | $ -293.28M | $ -409.65M | |
| $ -23.68M | $ -32.28M | $ -24.20M | $ 26.47M | $ -173.00K | |
| $ -93.52M | $ -93.32M | $ -188.82M | $ -266.81M | $ -409.82M | |
| $ -68.24M | $ -87.94M | $ -175.89M | $ -204.24M | $ -361.45M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.28 | $ -0.36 | $ -0.72 | $ -0.98 | $ -1.64 |
| Diluted EPS | $ -0.28 | $ -0.36 | $ -0.72 | $ -0.98 | $ -1.64 |
| Weighted Average Shares Outstanding | 243.42M | 243.42M | 243.42M | 243.42M | 243.94M |
| Weighted Average Shares Outstanding (Diluted) | 243.42M | 243.42M | 243.42M | 243.42M | 243.94M |
Currency in CNY
